Lung Cancer

A randomized phase 3 trial that evaluated nivolumab with concurrent chemoradiotherapy for certain patients with advanced lung cancer failed to meet its primary endpoint, according to the agent’s manufacturer.

An offer to speak with a smoking cessation practitioner during a lung cancer screening appointment was accepted by a majority of current smokers, according to results published in European Respiratory Journal.

Researchers developed a miniature “tumor farm” model that uses biopsied tumor cells to enable personalized, 3-D testing of the cells’ response to various lung cancer drugs.

Nearly 50% of patients with pretreated, locally advanced non-small cell lung cancer harboring a KRAS G12C mutation responded to treatment with glecirasib, findings from a phase 2 study conducted in China showed.

Researchers at Columbia University's Herbert Irving Comprehensive Cancer Center are investigating a lung cancer treatment that can be delivered directly to the lungs.

The FDA approved alectinib as an adjuvant treatment for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer following tumor resection and detection by an FDA-approved test.

Outcomes of using menopausal hormone therapy beyond age 65 years varied based on hormone therapy types, administration and strengths among women on Medicare, researchers reported in Menopause.

Durvalumab extended OS and PFS compared with placebo for patients with limited-stage small cell lung cancer, according to topline data released by the agent’s manufacturer.

Most adults have not tested their homes for radon, nor have they taken action to reduce radon exposure despite its link to cancer, a survey showed.

The FDA granted fast track designation to PT217, a novel bispecific antibody, for the treatment of adults with extensive-stage small cell lung cancer, according to a release from the manufacturer.